In Brief This Week: Novartis; Agilent; IntegraGen; Evotec, Apeiron | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Novartis this week said that it will invest more than $600 million over the next five years to expand its global research campus in Cambridge, Mass. The Cambridge site houses the Novartis Institutes for Biomedical Research, Novartis Molecular Diagnostics, Novartis Vaccines and Diagnostics, and the US office of Novartis Venture Funds.

The company expects the investment will include adding 300 jobs, however a company spokesperson declined to provide further details.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.